Takamatsu, Manabu https://orcid.org/0000-0001-9601-5802
Tanaka, Mariko
Masugi, Yohei
Inoue, Yosuke
Nagano, Hiroko
Le, Tho Ngoc-Quynh
Nishida, Kenji
Sawa, Yui
Sugiura, Kota
Kawaguchi, Yoshikuni https://orcid.org/0000-0003-2986-3224
Kazami, Yusuke
Nakai, Yousuke
Hamada, Tsuyoshi https://orcid.org/0000-0002-3937-2755
Suzuki, Tatsunori
Hara, Kensuke
Kurebayashi, Yutaka https://orcid.org/0000-0003-3773-0851
Takeda, Tsuyoshi
Sasahira, Naoki
Uematsu, Yosuke
Uemura, Sho
Fujishiro, Mitsuhiro https://orcid.org/0000-0002-4074-1140
Hasegawa, Kiyoshi
Kitago, Minoru
Takahashi, Yu https://orcid.org/0000-0003-3066-023X
Sekine, Shigeki
Ushiku, Tetsuo https://orcid.org/0000-0002-1763-8380
Takeuchi, Kengo https://orcid.org/0000-0002-1599-5800
,
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP21K15393)
MEXT | Japan Society for the Promotion of Science (JP20K07414)
MEXT | Japan Society for the Promotion of Science (JP19K08362)
MEXT | Japan Society for the Promotion of Science (JP22H02841)
MEXT | Japan Society for the Promotion of Science (JP21K15368)
MEXT | Japan Society for the Promotion of Science (JP23K15485)
Practical Research for Innovative Cancer Control Program from AMED
Article History
Received: 7 August 2025
Revised: 20 November 2025
Accepted: 3 December 2025
First Online: 8 January 2026
Competing interests
: YM and TH acknowledge research funding from the Daiichi Sankyo TaNeDS Funding Program. This work was not funded by this company. No other conflicts of interest exist. The other authors declare no conflicts of interest.
: This study was designed and conducted in accordance with the Declaration of Helsinki guidelines. Given the retrospective design of the study, informed consent was obtained from all patients on an opt-out basis. The study was approved by the ethics committee at each participating center and registered with the UMIN registry (registration number: UMIN000044027).